EVAX
USDEvaxion Biotech A/S American Depositary Share
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$5.570
उच्च
$6.010
कम
$5.570
मात्रा
0.09M
कंपनी के मौलिक सिद्धांत
बाजार पूंजीकरण
44.4M
उद्योग
जैव प्रौद्योगिकी
देश
Denmark
ट्रेडिंग आँकड़े
औसत मात्रा
1.59M
एक्सचेंज
NCM
मुद्रा
USD
52-सप्ताह रेंज
संबंधित समाचार
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed with our AI-Immunology™ platformEVX-04 is a therapeutic cancer vaccine candidate designed for
Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
Correcting press release issued under same heading: Date in body text corrected to "November 6, 2025" as in headline. COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a
Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report
संबंधित स्टॉक
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।